Actively Recruiting
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Led by Institut Claudius Regaud · Updated on 2026-02-10
400
Participants Needed
20
Research Sites
518 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characterization of sarcoma of rare subtype. 400 patients will be included in this prospective cohort study; they will be identified in the investigating centers in the context of either routine care or a clinical study protocol. Retrospective cases of patients (100 cases in total) will be identified in all centers through the GSF/GETO clinical databases already setted up (including the clinical base Conticabase).
CONDITIONS
Official Title
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of study entry
- Diagnosis confirmed by RRePS network of one of these rare sarcoma subtypes: Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasm, Desmoplastic Small Round Cell Tumor, Malignant Solitary Fibrous Tumor, Alveolar Soft Part Sarcoma, Epithelioid Hemangioendothelioma, Low-Grade Fibromyxoid Sarcoma, or Sclerosing Epithelioid Fibrosarcoma
- Localized, locally advanced, or metastatic disease
- For localized disease, treatment not started before inclusion except surgical excision
- For metastatic disease, a new systemic treatment line planned before inclusion
- Followed within standard care or clinical trial at the center
- Archived tumor specimen available from initial diagnosis before treatment
- Disease measurable or not as per RECIST 1.1
- ECOG performance status between 0 and 3
- Able and willing to give informed consent before any study procedures
- Affiliated with Social Health Insurance in France
You will not qualify if you...
- Diagnosis of any other soft tissue sarcoma histotypes
- Any condition preventing procedures required by the study protocol
- Known positive test for hepatitis B, hepatitis C, HIV, or AIDS
- Psychological, familial, geographic, or social factors preventing informed consent or study compliance as judged by investigator
- Pregnant or breastfeeding women
- Patients legally deprived of freedom or under guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 20 locations
1
Chu Besancon - Site Jean Minjoz
Besançon, France, 25000
Actively Recruiting
2
Institut Bergonié
Bordeaux, France
Actively Recruiting
3
Centre Jean Perrin
Clermont-Ferrand, France, 63011
Actively Recruiting
4
Centre Georges François Leclerc
Dijon, France
Not Yet Recruiting
5
Centre Oscar Lambret
Lille, France, 59020
Actively Recruiting
6
Chu Dupuytren
Limoges, France
Actively Recruiting
7
Centre Leon Berard
Lyon, France, 69008
Actively Recruiting
8
Institut Paoli-Calmettes
Marseille, France, 13009
Withdrawn
9
Chu de Marseille - Hopital de La Timone
Marseille, France
Actively Recruiting
10
Centre Antoine Lacassagne
Nice, France, 06189
Actively Recruiting
11
Hôpital Cochin - Site Port-Royal
Paris, France
Actively Recruiting
12
Institut Curie
Paris, France
Actively Recruiting
13
Chu Poitiers
Poitiers, France
Actively Recruiting
14
Institut Godinot
Reims, France
Actively Recruiting
15
Centre Eugene Marquis
Rennes, France
Actively Recruiting
16
Institut de Cancerologie de L'Ouest - Site Rene Gauducheau
Saint-Herblain, France, 44805
Withdrawn
17
Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Actively Recruiting
18
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, France
Actively Recruiting
19
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, France, 54519
Actively Recruiting
20
Institut Gustave Roussy
Villejuif, France, 94805
Withdrawn
Research Team
T
Thibaud VALENTIN
CONTACT
F
Frédéric CHIBON
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here